1. Home
  2. CORT vs CAE Comparison

CORT vs CAE Comparison

Compare CORT & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • CAE
  • Stock Information
  • Founded
  • CORT 1998
  • CAE 1947
  • Country
  • CORT United States
  • CAE Canada
  • Employees
  • CORT N/A
  • CAE N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • CAE
  • Sector
  • CORT Health Care
  • CAE
  • Exchange
  • CORT Nasdaq
  • CAE Nasdaq
  • Market Cap
  • CORT 7.5B
  • CAE 8.4B
  • IPO Year
  • CORT N/A
  • CAE N/A
  • Fundamental
  • Price
  • CORT $69.15
  • CAE $28.44
  • Analyst Decision
  • CORT Strong Buy
  • CAE Buy
  • Analyst Count
  • CORT 4
  • CAE 4
  • Target Price
  • CORT $142.00
  • CAE $32.50
  • AVG Volume (30 Days)
  • CORT 856.9K
  • CAE 648.8K
  • Earning Date
  • CORT 08-05-2025
  • CAE 08-12-2025
  • Dividend Yield
  • CORT N/A
  • CAE N/A
  • EPS Growth
  • CORT 8.36
  • CAE N/A
  • EPS
  • CORT 1.14
  • CAE 0.88
  • Revenue
  • CORT $685,446,000.00
  • CAE $3,275,402,649.00
  • Revenue This Year
  • CORT $35.85
  • CAE $8.43
  • Revenue Next Year
  • CORT $35.22
  • CAE $5.82
  • P/E Ratio
  • CORT $60.53
  • CAE $32.18
  • Revenue Growth
  • CORT 30.93
  • CAE 9.93
  • 52 Week Low
  • CORT $32.33
  • CAE $15.95
  • 52 Week High
  • CORT $117.33
  • CAE $30.13
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • CAE 49.70
  • Support Level
  • CORT $67.44
  • CAE $28.20
  • Resistance Level
  • CORT $73.78
  • CAE $29.90
  • Average True Range (ATR)
  • CORT 2.08
  • CAE 0.51
  • MACD
  • CORT -0.31
  • CAE -0.22
  • Stochastic Oscillator
  • CORT 26.97
  • CAE 12.90

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: